Grants and Contracts Details
Description
The overall goal of the present proposal is to determine the molecular/cellular mechanism(s) involved in the
maturation process of cumulus oocyte complexes (COCs). Proper maturation of the COC is critical to
reproductive success in vivo and in vitro. Our lack of a complete understanding of this maturation process
restricts our ability to manage fertiHty in vivo and hinders implementation of ART such as in vitro fertilization and
in vitro maturation. Recent studies by our laboratory and others have begun to shed light on a small family of
nuclear transcription factors, RUNX1 and RUNX2, as key transcriptional regulators involved in COC expansion.
Our preliminary data demonstrated that Runxi and Runx2 expression is highly induced in cumulus cells of
periovulatory follicles. We also found that RUNX1 and RtJNX2 regulate the expression of Ptgs2 (a rate-limiting
enzyme in the biosynthesis of prostaglandins) and Hap/ni (a stabilizer of cumulus matrix) in mural granulosa
cells and/or cumulus cells. Both gene products are known to play crucial roles in COC expansion. Most
importantly, our pilot study demonstrated that over-expression of dominant negative RUNX in cumulus cells
blocked COC expansion. Based on these novel findings, we hypothesized that RUNX1/2 are essential
transcriptional regulators necessary for the gonadotropin surge-induced COC expansion. This hypothesis will
be tested by first demonstrating the functional significance of RunxlI2 expression in cumulus cells (Aim #1).
Secondly, we will determine the regulation action(s) of RUNXI and RUNX2 on their target genes (Aim #2).
Next, we will determine the regulatory mechanism(s) of Runxi and Runx2 expression in cumulus cells (Aim #3).
These 3 Aims will be studied using rat COCs. To insure that the data obtained from rat studies is translatable to
humans, RUNX1/2 and their target gene expression profile will be also verified using human cumulus cells
collected throughout the periovulatory period. We will also examine the correlation of the cumulus expression
of RUNX1/2 and their target genes to oocyte quality, fertilization, and embryo development using COGs
obtained from women undergoing IVF (Aim #4). These human studies will serve as a foundation for future
translational/clinical application. The information obtained from the proposed studies will not only advance our
understanding of the mechanism involved in COC maturation, but also be instrumental for future
translational/clinical application(s), thus leading to improved management of fertility in vivo and in vitro.
Status | Finished |
---|---|
Effective start/end date | 9/24/10 → 5/31/15 |
Funding
- National Institute of Child Health and Human Develop: $963,230.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.